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TNFreceptor1signalinginducesNF-jBactivationandnecroptosisinL929cells.Wepreviouslyreportedthatcellularinhibitorof
apoptosis protein-mediated receptor-interacting protein 1 (RIP1) ubiquitination acts as a cytoprotective mechanism, whereas
knockdown of cylindromatosis, a RIP1-deubiquitinating enzyme, protects against tumor necrosis factor (TNF)-induced
necroptosis. We report here that RIP1 is a crucial mediator of canonical NF-jB activation in L929 cells, therefore questioning the
relative cytoprotective contribution of RIP1 ubiquitination versus canonical NF-jB activation. We found that attenuated NF-jB
activation has no impact on TNF-induced necroptosis. However, we identiﬁed A20 and linear ubiquitin chain assembly complex
asnegativeregulatorsofnecroptosis.Unexpectedly,andincontrasttoRIP3,wealsofoundthatknockdownofRIP1didnotblock
TNF cytotoxicity. Cell death typing revealed that RIP1-depleted cells switch from necroptotic to apoptotic death, indicating that
RIP1 can also suppress apoptosis in L929 cells. Inversely, we observed that Fas-associated protein via a death domain, cellular
FLICE inhibitory protein and caspase-8, which are all involved in the initiation of apoptosis, counteract necroptosis induction.
Finally, we also report RIP1-independent but RIP3-mediated necroptosis in the context of TNF signaling in particular conditions.
Cell Death and Disease (2011) 2, e230; doi:10.1038/cddis.2011.111; published online 17 November 2011
Subject Category: Cancer
Tumor necrosis factor (TNF) is a pleiotropic cytokine that
binds and activates TNF receptor 1 and 2 (TNFR1 and
TNFR2). In most cell types, TNFR1 signaling promotes cell
survival by triggering expression of pro-survival genes
through activation of the canonical NF-kB pathway. However,
when protein synthesis is inhibited, TNFR1 activation turns
into a death signal.
1 Upon activation, TNFR1 trimers undergo
a conformational change that allows the cytosolic part of the
receptor to recruit TNFR-associated death domain (TRADD),
receptor-interacting protein 1 (RIP1) and TNFR-associated
factor 2 (TRAF2).
2,3 Subsequently, TRAF2 binds to cellular
inhibitor of apoptosis proteins 1 and 2 (cIAP1/2), which allow
recruitment of the linear ubiquitin chain assembly complex
(LUBAC) to ﬁnally generate a membrane-proximal supramo-
lecular structure called the TNFR1 complex I (TNFR1-CI).
4
Within this complex, non-degradative polyubiquitin chains are
conjugated to RIP1 by cIAP1/2 (Bertrand et al.
5) and those
chains were reported to serve as scaffolds for the recruitment
and activation of the TAB–transforming growth factor-b-
activated kinase 1 (TAK1) complex and the inhibitor of
NF-kB kinase (IKK)a–IKKb–NF-kB essential modulator
(NEMO) complex, resulting in NF-kB activation and transcrip-
tional upregulation of pro-survival genes.
6,7 A recent study
using RIP1-deﬁcient cells, however, challenged the common
notion that RIP1 is absolutely required for TNF-induced NF-
kB activation, suggesting that other ubiquitinated proteins
within complex I can recruit and activate the TAB-TAK1 and
the IKKa–IKKb–NEMO complexes.
8
Upon internalization of ligand-bound TNFR1, the molecular
composition of the TNFR1-CI changes and initiates the
formation of a cytosolic death-inducing signaling complex,
better known as TNFR1 complex II (TNFR1-CII).
3 RIP1
polyubiquitination not only affects the NF-kB activation, but
also inﬂuences the transition from TNFR1-CI to TNFR1-
CII.
5,9,10 Upon deubiquitination of RIP1 by cylindromatosis
(CYLD),
11RIP1isrecruitedtosupramolecular complexesthat
include at least TRADD, Fas-associated protein with a death
domain (FADD), RIP1, RIP3 and caspase-8.
3,12 It remains
unclear whether other RIP1-deubiquitinating enzymes such
as A20 also stimulate the lethal functions of RIP1. In TNFR1-
CII, caspase-8 inactivates RIP1 and RIP3 by proteolytic
cleavage and initiates the pro-apoptotic caspase activation
cascade.
12,13 The activation and release of caspase-8 is
controlled by cellular FLICE inhibitory protein (c-FLIP).
14
By contrast, when caspase-8 is deleted, depleted or
inhibited by CrmA or pharmacological agents, TNFR1-CII
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results (at least in some cell types) in necroptosis.
15–17 These
ﬁndings are underscored by the observation that the
embryonic lethality of caspase-8-deﬁcient mice is rescued
by RIP3 deletion.
17,18 Whether FADD or TRADD is strictly
required to assemble the necroptosis signaling complex, or
‘necrosome’, is still controversial.
15 In favor of an anti-necrotic
functionforFADDistheobservationthatFADD-deﬁcientmice
display massive necrosis, contain elevated expression levels
of RIP1, are embryonic lethal and could be rescued by RIP1
deletion.
19 BothRIP1andRIP3kinaseactivitiesarecrucialfor
TNF-induced necroptosis,
20 but the molecular mechanisms
regulating this type of cell death are still enigmatic. Until
recently, necrosis was deﬁned, in contrast to apoptosis, as an
accidental and uncontrolled type of cell death. The term
‘necroptosis’ was originally introduced to indicate regulated
necrosis,
21 but it was later on found to be RIP1 dependent.
22
However, RIP3-dependent necrosis can also proceed without
the need for RIP1. Indeed, RIP3 overexpression or viral
infection has been reported to induce necrosis independently
of RIP1.
23,24 Therefore, the Nomenclature Committee on Cell
Death proposed that ‘necroptosis’ can be used to indicate
RIP1- and/or RIP3-dependent regulated necrosis.
25 Under-
standing the regulation of necroptosis is a key priority,
especially in the light of recent in vivo studies reporting the
importance of necroptosis in several pathological condi-
tions.
20 The murine ﬁbrosarcoma L929 cell line is a well-
established cellular model to study necroptosis. In these cells,
TNFR1 signaling induces NF-kB activation and necroptosis in
the absence of caspase or protein synthesis inhibitors.
16
Using this model, we previously reported a cytoprotective role
for cIAP1 and TAK1 in TNF-induced necroptosis.
26 Our
resultsindicatedthatcIAP1-mediatedRIP1ubiquitinationacts
as a major protective mechanism against necrosome forma-
tion. Consistently, we and others found that repressing CYLD,
a RIP1-deubiquitinating enzyme, protects L929 cells against
TNF-induced necroptosis.
26,27
In this study, we found that RIP1 is a crucial mediator
of canonical NF-kB activation in L929 cells, therefore
questioning the relative contribution of RIP1 ubiquitination
versus canonical NF-kB activation as cytoprotective events
against TNF-induced necroptosis. To answer this question,
weinvestigatedtheroleofotherTNFR1-CIcomponentsinour
necroptotic cellular model. Interestingly, we found that
attenuation of NF-kB activation has no impact on TNF-
induced necroptosis, which led us to the identiﬁcation of an
unexpected regulatory role of A20, another RIP1-deubiquiti-
natingenzyme,andforLUBACinnecroptosisinduction.Inthe
light of the still controversial contribution of the TNFR1-CII
members to the cell death outcome, we investigated their role
in the cell death modality decision by depleting them.
This approach revealed that FADD, c-FLIPL and caspase-8,
which are all involved in the initiation of apoptosis,
counteract necroptosis induction. In addition, we found
that RIP1 but not RIP3 repression induces a switch from
TNF-induced necroptosis to TNF-mediated apoptosis,
indicating that RIP1 suppresses apoptosis in this cellular
system. Finally, we also report RIP1-independent but
RIP3-dependent necroptosis in the context of TNF signaling
in L929 cells.
Results
Knockdown of heme-oxidized iron regulatory protein
2 ubiquitin ligase-1 (HOIL-1), HOIL-1-interacting protein
(HOIP) or A20 sensitizes cells to TNF-induced necroptosis,
whereas depletion of TRADD or NEMO does not affect cell
viability. In contrast to the situation observed in most cell
types, TNFR1 signaling in the mouse L929 ﬁbrosarcoma
cell line activates NF-kB and also induces cell death
(necroptosis), in the absence of synthetic caspase or
protein synthesis inhibitors.
16 Using this cellular system,
we previously reported that depletion of cIAPs resulted in
necrosome complex formation and strongly sensitized the
cells to TNF-induced necroptosis.
26 Interestingly, we now
provide data showing that repression of RIP1 levels by RNAi
almost completely inhibits TNF-mediated IkBa degradation
in L929 cells (Figure 1a), indicating that RIP1 is a major
regulator of TNF-induced NF-kB activation in these cells.
Within TNFR1-CI, cIAP-mediated RIP1 ubiquitination is
important to prevent RIP1 from integrating into death-
inducing TNFR1-CII.
5,9 In addition, the conjugation of
non-degradative ubiquitin chains to RIP1 is important for
NF-kB activation, another cytoprotective event. To explore
the contribution of each process to cell death prevention, we
analyzed the effect of depleting proteins reported to be
involved in the regulation of each cytoprotective process on
TNF-induced necroptosis. TRADD,
28,29 NEMO
30 and
LUBAC (HOIL-1 and HOIP)
4,31 were all reported to be
important positive regulators of TNF-mediated NF-kB
activation and we found that repressing each of these
proteins by RNAi led to an approximately similar inhibition
of IkBa degradation upon TNF stimulation in L929 cells
(Supplementary Figure 1a). Interestingly, silencing of NEMO
and TRADD had no impact on TNF-mediated necroptosis
(Figures 1b and c). In contrast, repression of the LUBAC
component HOIL-1 or HOIP enhanced TNF-induced cell
death (Figure 1d), indicating that the sensitization to death
upon LUBAC knockdown is independent of NF-kB activation.
However, it should be noted that knockdown of HOIP is more
potent in promoting TNF-induced cell death than silencing of
HOIL-1 (Figure 1e). To determine the cell death type in these
sensitized conditions upon knockdown of HOIL-1 or HOIP,
we stably transfected a Fo ¨rster Resonance Energy Transfer
(FRET)-based apoptosis sensor construct into L929 cells to
detect caspase-3 activity, hereafter referred to as
L929pCasper3-BG cells. In these cells, silencing of HOIL-1
or HOIP increased the amount of cell death (Supplementary
Figure 2a) without any caspase-3 activity (Supplementary
Figure 2b), indicating that the enhanced cell death type was
not due to a shift to apoptosis. CYLD is a RIP1-
deubiquitinating enzyme,
11 and we and others previously
showed that CYLD repression protects L929 cells from TNF-
induced necroptosis,
26,27 consistent with the cytoprotective
role of non-degradative ubiquitination of RIP1. A20 is another
RIP1-deubiquitinating enzyme reported to negatively
regulate TNF-induced NF-kB activation.
32 Repression
of A20 was therefore expected to protect cells from TNF-
induced necroptosis. Instead, we were surprised to ﬁnd that
A20 depletion had an opposite effect and greatly sensitized
the cells to death (Figures 1f and g). Performing this
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Cell Death and Diseaseexperiment in L929pCasper3-BG cells demonstrated
that A20 silencing enhances cell death (Supplementary
Figure 2c) in the absence of any caspase-3 activity upon
TNF stimulation (Supplementary Figure 2d). It is important to
note that this sensitization is also NF-kB independent,
because A20 depletion did not inhibit early NF-kB
activation (Supplementary Figure 1b). Together, these
results indicate that NF-kB activation does not have a
major protective role against TNF-induced necroptosis in
L929 cells. In addition, we identiﬁed the LUBAC components
HOIL-1 and HOIP, as well as the deubiquitinase A20, as
negative regulators of TNF-mediated necroptosis.
Knockdown of FADD, caspase-8 or c-FLIP sensitizes
to TNF-induced necroptosis. Upon TNF stimulation,
deubiquitination of RIP1 allows formation of the cytosolic
death-inducing TNFR1-CII.
3.This complex, which consists of
at least TRADD, FADD, caspase-8, RIP1 and RIP3, allows
the induction of apoptosis or necroptosis, depending on the
cellular context.
20 To test the requirement for these proteins
in TNF-induced necroptosis in L929 cells, we targeted them
by RNAi. Knockdown of FADD or caspase-8 strongly
enhanced TNF-induced cell death as a function of time
(Figures 2a and b), and sensitized TNF-induced cell death
by 30-fold based on IC50 values (Figures 2a and c). In
L929pCasper3-BG cells, knockdown of caspase-8 enhanced
the amount of cell death (Supplementary Figure 3a) upon
TNF stimulation without showing any caspase-3 activity
(Supplementary Figure 3b). In addition, the increased
amount of cell death following caspase-8 knockdown and
TNF treatment was strongly reduced in the presence of the
RIP1 kinase inhibitor necrostatin-1 (Nec-1) (Supplementary
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Figure 1 Knockdown of HOIL-1, HOIP or A20 sensitizes to TNF-induced necroptosis, whereas depletion of TRADD or NEMO does not affect the cell viability. (a) Upon
knockdown of RIP1, L929 cells were stimulated with TNF for the indicated times. IkBa degradation and RIP1 knockdown efﬁciency was analyzed using western blotting.
Asterisk indicates an nonspeciﬁc band. Flow cytometric analysis of the percentage of Sytox-positive cells after TNF stimulation for 4h (reaching around 50% cell death in
control setup) of L929 cells in which TRADD or NEMO (b), HOIL-1 or HOIP (d), or A20 was knocked down (f). Error bars indicate S.D.s of triplicates of three independent
experiments.CellsurvivalanalysisusingaMTTassayafter20hofTNFstimulationofL929cellsinwhichTRADDorNEMO(c),HOIL-1orHOIP(e),orA20wasknockeddown
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Cell Death and DiseaseFigure 3a). Together, these data demonstrate that silencing
of caspase-8 sensitizes L929 cells to TNF-induced necro-
ptosis and are in agreement with other studies reporting the
negative regulatory role of caspase-8 in necroptosis in Jurkat
and primary T cells
33 and in benzyloxycarbonyl-Val-Ala-
Asp(OMe)-ﬂuoromethylketone (zVAD)-fmk-induced RIP3-
dependent cell death in L929 cells.
17 Interestingly, down-
regulation of c-FLIP, a regulator of caspase-8 activation,
17
also strongly enhanced (Figure 2b) and sensitized cell death
by 10-fold on TNF stimulation (Figure 2c). We reasoned that
c-FLIP downregulation would result in increased formation of
active caspase-8 dimers within TNFR1-CII, and would induce
a switch to apoptotic cell death. However, the use of
the FRET-based apoptosis sensor revealed that the L929p
Casper3-BG cells depleted of c-FLIP still died in a caspase-
independent way when exposed to TNF (Supplementary
Figures 4a and b), thereby conﬁrming the study of Oberst
et al.
17 showing that in L929 cells, c-FLIP silencing promotes
zVAD-fmk-induced cell death that is RIP3-dependent.
Live-cell imaging of TNF-treated cells conﬁrmed the
necrotic morphology (Supplementary Figure 4c) of these
sensitized cells. In contrast, our control, consisting of Fas
receptor-mediated apoptosis, showed increased apoptosis
upon knockdown of c-FLIP (Supplementary Figures 4a and
b). Together with the previous results, these data indicate
that the adaptor proteins TRADD and FADD apparently have
different roles in TNFR1-induced necroptosis. Whereas
TRADD is dispensable for TNF-induced necroptosis, the
key molecules of the apoptotic axis, FADD, caspase-8 and
c-FLIP, counteract TNF-induced necroptosis.
Knockdown of RIP1 but not of RIP3 switches
TNF-induced TRADD-independent necroptosis to
TRADD-dependent apoptosis. RIP1 and RIP3 kinases
have a crucial role in TNF-induced necroptosis.
12,15,23,34
Previous reports showed that silencing RIP3 expression
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Cell Death and Diseaserescued L929 cells from TNF-induced necroptosis.
12,23,26,34
Surprisingly, RIP1 knockdown did not protect L929 cells from
TNF-induced cell death (Figure 3a). Because RIP1 depletion
does block TNF-induced necroptosis in the presence of the
pan-caspase inhibitor zVAD-fmk in L929 cells,
12,35 we
reasoned that RIP1 depletion may have resulted in a shift
to apoptosis. This hypothesis is underscored by our previous
ﬁnding that chemical inhibition of heat shock protein 90,
which results in degradation of its client proteins, such as
RIP1,
36 resulted in a shift from TNF-induced necroptosis to
apoptosis.
37 Use of the FRET-based apoptosis sensor
demonstrated that lowering RIP1 levels by RNAi indeed
resulted in rapid induction of apoptosis in response to TNF
stimulation (Figure 3c), as also revealed by proteolytic
activation of caspase-3 (Figure 3b) and apoptotic blebbing
(Figure 3d). Because TRADD and RIP1 compete for TNFR1
binding,
38 we reasoned that TRADD contributes to this
switch to apoptosis upon RIP1 loss. Indeed, knockdown of
TRADD blocked TNF-induced caspase activity in the
absence of RIP1 and strongly reduced cell death
(Figure 3c). In summary, these data show that RIP1
depletion in L929 cells results in a shift from TRADD-
independent necroptosis (Figure 1b) to TRADD-dependent
apoptosis in response to TNF.
RIP3-dependent necroptosis upon knockdown of RIP1
and caspase-8. Using a similar approach as above, we
found that RIP1 and caspase-8 double knockdown
completely inhibits caspase-mediated apoptosis on TNF
stimulation without affecting the extent of cell death
(Figure 4a), indicating a switch to a RIP1-independent type
of necrosis. A triple knockdown revealed that silencing RIP1,
caspase-8 and RIP3 resulted in complete protection,
demonstrating that the absence of RIP1 and caspase-8
leads to a strong bias toward RIP3-dependent necrosis
(Figure 4a). Similarly, TNF-induced necrosis of cells in which
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Cell Death and Diseaseboth RIP1 and TRADD were knocked down was completely
rescued when RIP3 was also silenced (Figure 4b). We
conclude that knockdown of caspase-8 in RIP1-deﬁcient
conditions clearly prevents TNF-induced apoptosis but still
allows a regulated form of necrosis, which depends solely on
RIP3. These results indicate that under particular conditions,
TNF-mediated RIP3-dependent necrosis can occur in the
absence of RIP1.
Discussion
TNF-induced necroptosis is a regulated form of cell death
involving the kinase activity of RIP1 and RIP3 in its initiation
phase.
20 However, still little is known about the regulatory
mechanisms that modulate sensitivity to TNF-induced
necroptosis. In this study, we examined the impact
of repressing proteins known to be recruited to TNFR1-CI
and/or TNFR1-CII on the decision of L929 cells to die in a
necroptotic way.
Within TNFR1-CI, cIAP1/2 conjugates RIP1 with non-
degradative ubiquitin chains,
5 and this event has been reported
to prevent RIP1 from integrating in complex II.
5,9 Our initial
observation that cIAP1 protects L929 cells from TNF-induced
necroptosis suggested that RIP1 ubiquitination also inhibits
necrosome formation.
26 The ﬁnding that RIP1 is a crucial
mediator of TNF-induced NF-kB activation in L929 cells then
questioned the relative contribution of NF-kB activation to the
cytoprotective mechanism mediated by ubiquitinated RIP1.
S i l e n c i n go fN E M Oo rT R A D Dd i dn o ts e n s i t i z et oT N F - i n d u c e d
necroptosis, whereas knockdown of the LUBAC component
HOIP and to lesser extent HOIL-1 enhanced TNF-induced
necroptosis, although all repressions resulted in approximately
similar reductions of IkBa degradation in response to TNF.
Together, these results indicate that NF-kB activation does not
have a major cytoprotective role in this cellular system and
revealed a negative regulatory function of LUBAC on TNF-
induced necroptosis. Recruitment of LUBAC to TNFR1-CI has
been reported to stabilize the complex.
4 It is therefore
conceivable that repressing LUBAC components destabilizes
TNFR1-CI and facilitates necrosome formation.
The observation that CYLD knockdown rescues L929 cells
from TNF-induced necroptosis
26,27 suggests that RIP1
deubiquitination is required for the initiation of necroptosis.
Beside CYLD,
11 RIP1 is also deubiquitinated by A20 in
the TNF signaling pathway.
32 However, in contrast to
the suppression of necroptosis by CYLD knockdown, A20
silencing elevated the sensitivity to TNF-induced necroptotic
celldeath.Thus,althoughbothCYLDandA20areRIP1lysine
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Cell Death and Disease63-deubiquitinating enzymes, they seem to act differently
during TNF-induced necroptosis. The sensitization to necrop-
tosis by A20 depletion agrees with the observation that A20
overexpression inhibits TNF-induced necroptosis in L929
cells,
39 as well as the TNF-induced caspase-independent cell
death of macrophages.
40 In contrast to CYLD, A20 has been
reportedtopossessE3ubiquitinligaseactivityinadditiontoits
deubiquitinase properties.
32 It is therefore possible that either
the deubiquitinase activity or the E3 ubiquitin ligase activity of
A20 inhibits or activates the pro-death or pro-survival
potential, respectively, of components of TNFR1-CI, but also
ofTNFR1-CII.Itisalsoimportanttonotethatthecytotoxicrole
of CYLD in necroptosis induction might not be at the level of
RIP1 or not only at the level of RIP1. Indeed, we found that
CYLD repression also protects L929 cells from hydrogen
peroxide-induced necrosis (Supplementary Figure 5), which
occurs independently of RIP1 and RIP3.
12,35
TNFR1-CII is formed downstream of TNFR1-CI. This
cytosolic death-inducing complex is composed of RIP1,
RIP3, FADD, TRADD and caspase-8. Whether TRADD
is strictly required in TNF-induced necroptosis signaling is
controversial.InJurkatTcells,TRADDdepletionhadnoeffect
on TNF-induced necroptosis,
38 whereas TRADD-deﬁcient
mouse embryonic ﬁbroblast (MEF) cells, but not macro-
phages, are protected against necroptosis induced by TNF in
the presence of CHX and zVAD-fmk.
28 In line with the Jurkat
data, which do not need CHX for necroptosis induction, we
found that TRADD depletion in L929 cells did not affect
TNF-induced necroptosis. However, in RIP1-knockdown
conditions, we observed that TRADD is important for TNF-
mediated apoptosis, suggesting that the role of TRADD in cell
death induction depends on the cellular condition.
Several independent reports have shown that RIP1
depletion blocks TNF-induced necroptosis in the presence
of the caspase inhibitor zVAD-fmk,
12,35 but fails to do so
in the absence of zVAD-fmk.
27 We found that in L929 cells
knockdown of RIP1, but not RIP3, even potentiates
TNF-induced cell death and shifts it from necroptosis to
apoptosis (Figure 5), which most probably explains why RIP1
depletion in the absence of zVAD-fmk does not block cell
death in L929 cells.
27 RIP1 knockout mice die shortly after
birth due to massive apoptosis, which was initially explained
by the absence of NF-kB activation and concomitant reduced
survival signaling.
41 The exclusive link between RIP1 and NF-
kB activation has now been challenged because several cell
types from RIP1-deﬁcient embryos still activated NF-kB upon
TNF stimulation.
8 We observed in L929 cells a switch to
apoptosis even when RIP1 knockdown was less efﬁcient and
did not affect NF-kB activation (data not shown), indicating
that RIP1 may fulﬁll an anti-apoptotic role independently of its
NF-kB-modulating activity. RIP1-mediated suppression of
apoptosis is not due to phosphorylation of the pro-apoptotic
proteins FADD and caspase-8 because inhibition of RIP1
kinase activity by Nec-1 did not induce apoptosis upon TNF
stimulation.
26,35 RIP1 and TRADD compete for TNFR1
binding.
2,38 Therefore, it is conceivable that loss of RIP1
enhances the recruitment of TRADD, which has been
reported to favor the induction of apoptosis.
38 Additionally,
RIP1 deﬁciency was shown to result in depletion of c-FLIP,
42
which is also an apoptosis sensitizing condition. Taken
together, both enhanced TRADD recruitment and decreased
levels of c-FLIP may account for the shift from necroptosis
to apoptosis in response to TNF.
We observed that combined knockdown of RIP1 and
TRADD completely blocks TNF-induced apoptosis, but
allows, to some extent, RIP3-dependent induction of necrotic
celldeathinL929cells.SimultaneousknockdownofRIP1and
caspase-8 also rescues from apoptotic cell death, but still
allows full blown induction of cell death, which can beinhibited
by RIP3 silencing. This indicates that when both RIP1 and
caspase-8 are absent, TRADD probably recruits FADD/RIP3
because these proteins interact constitutively.
12 Although it
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Figure 5 Summary of the RNAi study of TNF-induced necroptosis in L929 cells. At TNFR1 complex II, the apoptotic proteins FADD, caspase-8 and c-FLIP suppress
TNF-induced necroptosis. RIP1 knockdown shifts TNF-induced TRADD-independent necroptosis to TRADD-dependent apoptosis. The combined knockdown of RIP1 and
caspase-8 blocks apoptosis but does not affect the extent of cell death. This RIP1-independent necroptotic cell death can be blocked by deleting RIP3 as well.
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Cell Death and Diseasewas shown that the TNF-induced assembly of the necrosome
requires RIP1 kinase activity,
12,34 our results provide a model
in which necrosome formation and subsequent necroptosis
occur in the absence of RIP1. This implies that certain cellular
conditions may bypass the need for RIP1 in necrosome
assembly and RIP3 activation. Indeed, a similar RIP1-
independent but RIP3-dependent necroptosis upon ectopic
expressionofRIP3hasbeendescribedinRIP1-deﬁcientMEF
cells
23 and more recently during viral infection.
24
This RNAi study in L929 cells demonstrates how knock-
down of several TNF-signaling proteins involved in TNFR1-CI
and II strongly modulate TNF-induced necroptosis (Table 1).
Considering the similarity between the observations in L929
cells and other cellular systems related to TNF-induced
signaling,
12,15,22,23,34 and the conﬁrmation thereof in an
in vivo context,
17,18,23 we consider L929 cells as a good
in vitro cellular system to study molecular cell death signaling
in response to TNF. These results provide a lead for testing
the role of these proteins in experimental in vivo models of
diseasesinwhichnecroptosisispresumedtohavearole.This
istheﬁrstreport(i)illustratingacytoprotectiveroleforA20and
LUBAC in TNF-induced necroptosis, (ii) explaining why RIP1
depletion in the absence of zVAD-fmk does not block cell
death, due to a switch toward apoptosis and (iii) showing
RIP3-dependentnecroptosis inductioninthe absenceofRIP1
in the context of TNF signaling. Finally, our results could have
important therapeutic implications for strategies aiming to
sensitize necroptosis to bypass the resistance of tumor cells
to apoptosis or to induce a more immunogenic form of cell
death. Desensitizing necroptosis could be therapeutically
usefulindegenerative diseasessuchasischemia-reperfusion
damageduringheartfailure,stroke,diabetestypeIIandorgan
transplantation.
20
Materials and Methods
Materials. We used TNF and Fas antibody to stimulate cell death. Recombinant
human TNF was produced and puriﬁed in our laboratory to at least 99%
homogeneity,anditsspeciﬁcbiologicalactivitywas3 10
7IU/mg.Weusedhuman
TNF because it is a speciﬁc agonist for murine TNFR1 and does not act on TNFR2.
Anti-human Fas antibody clone 2R2 was from Cell Diagnostica, Munster, Germany.
H2O2 30% and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)
(SigmaAldrich,St.Louis,MO,USA)wasusedat2mMand500mg/ml,respectively.
Lossof plasma membranepermeability was monitored using 5nM Sytox Red Dead
Cell Stain (Molecular Probes–Invitrogen, Eugene, OR, USA) and 3mM propidium
iodide (PI, Sigma Aldrich). Nuclei were stained using Hoechst 33242 (Molecular
Probes–Invitrogen). The following antibodies were used for western blot analysis:
anti-HOIL-1 antibody(gift fromH Walczak);anti-b-tubulin (HRP)(Ab21058,Abcam,
Cambridge, UK); anti-b-actin (Clone C4, MP Biomedicals Europe NV, Illkirch,
France); anti-caspase-8 (1G12, Alexis, Enzo Life Sciences, Zandhoven, Belgium);
anti-RIP1 (610459, BD Biosciences, Franklin Lakes, NJ, USA); anti-RIP3 (R4277,
Sigma Aldrich); rabbit polyclonal antibody against full-length murine caspase-3
(made in-house); cleaved caspase-3 antibody (9661; Cell Signaling Technology,
Danvers, MA, USA). Antibodies to A20 (A-12), FADD (M-19), IkBa (C-21), NEMO
(FL-419) and TRADD (H-278) were purchased from Santa-Cruz Biotechnology
(Santa Cruz, CA, USA).
Celllines. L929sAhFas cells were producedby expressing the humanFas gene
in L929sA cells, a TNF-sensitive derivative of the murine ﬁbrosarcoma cell line
L929.
16.These cells are referred to as L929 cells and were cultured in Dulbecco’s
modiﬁed Eagle’s medium supplemented with 10% fetal calf serum, penicillin
(100IU/ml), streptomycin (0.1mg/ml), and L-glutamine (0.03%). L929pCasper3-BG
cells were made by transfecting the pCasper3-BG vector (FP970; Evrogen,
Moscow, Russia) into L929sAhFas cells by the calcium phosphate method.
After transfection, cells were sorted fourtimes using the BeckmanCoulter Altra ﬂow
cytometer (Beckman Coulter, Brea, CA, USA) to obtain L929pCasper3-BG cells
with strong expression of pCasper3-BG.
Analysis of cell survival, cell death and caspase-3 activity. L929
or L929pCasper3-BG cells were pretreated with Nec-1 for 1h and then stimulated
with TNF (10000IU/ml) or anti-Fas (125ng/ml) for the indicated periods. Death of
L929 cells was analyzed by ﬂow cytometry on a dual-laser FACSCalibur (488nm,
635nm) with Cellquest software (BD Biosciences). Simultaneous analysis
of cell death and caspase-3 activity in L929pCasper3-BG cells was performed
using a triple-laser LSR-II (405, 488 and 635nm) with FACSDiva software
(BD Biosciences). Cell death or loss of plasma membrane integrity was determined
by measuring Sytox Red (Molecular Probes–Invitrogen, Eugene, OR, USA) or
propidium iodide (PI)-emitted ﬂuorescence. Caspase-3 activity was determined by
Casper3-BG, a FRET-based apoptosis sensor consisting of the blue ﬂuorescent
protein TagBFP connected by a DEVD sequence with a green ﬂuorescent protein,
TagGFP2.Duringapoptosis,cleavageofDEVDby caspase-3 eliminatesFRETand
increasestheTagBFP:TagGFP2ratio.Onlyviablecells(PInegative)weregatedfor
analysis of caspase-3 activity. All experiments were performed at least twice in
triplicate. Cell survival was determined by a MTT assay. After 20h of TNF
stimulation, MTT was added at 500mg/ml for 4h, followed by lysis in 10%
SDS/ 0.1M HCl. Absorbance was measured using a standard microplate reader
with a 595-nm ﬁlter and a 655-nm reference ﬁlter.
RNAi-mediated knockdown. L929 and L929pCasper3-BG cells were
transfected in six-well plates according to the manufacturer’s protocol using
20nM siRNA targeting A20, caspase-8, c-FLIP, HOIL-1, HOIP, NEMO, RIP1, RIP3
and TRADD (mixture of four siRNAs, ON-TARGETplus SMART pool siRNA,
Dharmacon, Thermo Fisher Scientiﬁc, Waltham, MA, USA). As a negative control,
we used siCONTROL non-targeting siRNA (ON-TARGETplus SMART pool siRNA,
Dharmacon). INTERFERin (Polyplus-transfection SA, Illkirch, France) was used as
a transfection reagent. Knockdown of FADD was performed by retroviral infection
with a pRetroSuper construct (DNAengine Inc., Seattle, WA, USA) containing
the sense-strand sequence 50-CAGACTTTCAGACTCTCCCTT-30. A scrambled
pRetroSupershRNAwasusedasanegativecontrol.First,shRNAswereintroduced
in QNX-A cells (Nolan Lab, Stanford, CA, USA) by calcium phosphate transfection.
After 24 and 48h, viral supernatant of QNX-A cells was harvested, polybrene
(SigmaAldrich)wasadded(16mg/ml)andviralsupernatantwasusedtoinfectL929
cells by centrifugation at 1500r.p.m. at 321C for 90min. After 72 or 96h of
knockdown by siRNA or shRNA, cells were stimulated with TNF and cell death was
determined as described above. Knockdown efﬁciency was checked by western
blot or RT-PCR.
RT-PCR. RNA was prepared from L929 cells using the RNeasy Plus Mini Kit
(Qiagen, Hilden, Germany). Starting with 2mg RNA, cDNA was synthesized
usingtheSuperScriptReverseTranscriptaseIIIkit(Invitrogen,Carlsbad,CA,USA).
PCRwasperformedusingGoTaqGreenMastermix(Promega,Madison,WI,USA).
Table 1 Overview of knockdowns for TNF-induced necroptosis in L929 cells
RNAi target Role in TNF-induced necroptosis
Complex I
cIAP1 Anti-necroptotic
HOIL-1 HOIP
TAK1 NEMO No apparent role or redundancy
I and II
TRADD No apparent role or redundancy
RIP1 Pro-necroptotic and anti-apoptotic
Complex II
FADD caspase-8 c-FLIP Anti-necroptotic
RIP3 Pro-necroptotic
DUB
A20 Anti-necroptotic
CYLD Pro-necroptotic
Abbrevietion: DUB, deubiquitinating enzymes. Knockdown of proteins involved
in TNFR1 complex I or II.
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Cell Death and DiseasePCR products were separated on 2% agarose gel and visualized by SYBR
Safe DNA gel stain (Molecular Probes–Invitrogen). The following primers were
used: c-FLIPL: Fwd 50- CCTCCAGCTCATCCTCTGTG-30 and Rev 50-TTTGTCCAT
GAGTTCAACGTG-30; c-FLIPR: Fwd 50- GCTGCTGTGGTTCTGAACATG-30 and
Rev 50-GGTACTCCATACACTGGCTCC-30; HOIP: Fwd 50- GCTTCATCTATGAAC
GCGAAC-30 and Rev 50- ATTGGTGCGTTTCCAGTTCT-30.
Microscopy. Time-lapse microscopy of L929 cells grown in eight-well Lab-Tek
chambers (Nunc, VWR international, Heverlee, Belgium) was carried out using a
Leica AS MDW live cell imaging system (Leica Microsystems, Mannheim,
Germany). This system includes a DM IRE2 microscope (Leica Microsystems,
Mannheim, Germany) equipped with an HCX PL APO 63 /1.3 glycerin corrected
371C objective and a 12-bit Coolsnap HQCamera. The microscope is surrounded
by an incubation chamber, which maintains the cells at 371C in a 5% CO2
environment. Cell morphology was observed by using differential interference
contrast (DIC). Cells were monitored for 8h, and multiple image z-stacks were
captured every 5min. Within the z-stack, different focal planes were set at 1-mm
intervals to prevent loss of focus during the process of cell death. Hoechst 33342
was excited at 380nm and emission was detected using a BP340/80/FT400/LP425
ﬁltercube.PI wasexcitedat540nmandtheemissionwasdetectedusinga BP515-
560/FT580/LP590 ﬁlter. From each image stack, maximum intensity projections
(for Hoechst and PI) and autofocus images (for DIC) were made for each time
point by using a script developed in-house for Fiji public domain imaging software
(http://ﬁji.sc/wiki/index.php/Fiji).
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